These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30854451)

  • 21. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
    Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
    Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
    Harris RJ; Cloughesy TF; Pope WB; Godinez S; Natsuaki Y; Nghiemphu PL; Meyer H; Paul D; Behbahanian Y; Lai A; Ellingson BM
    J Neurooncol; 2013 Apr; 112(2):257-66. PubMed ID: 23344788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
    Fathi Kazerooni A; Akbari H; Shukla G; Badve C; Rudie JD; Sako C; Rathore S; Bakas S; Pati S; Singh A; Bergman M; Ha SM; Kontos D; Nasrallah M; Bagley SJ; Lustig RA; O'Rourke DM; Sloan AE; Barnholtz-Sloan JS; Mohan S; Bilello M; Davatzikos C
    JCO Clin Cancer Inform; 2020 Mar; 4():234-244. PubMed ID: 32191542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.
    Juan-Albarracín J; Fuster-Garcia E; Pérez-Girbés A; Aparici-Robles F; Alberich-Bayarri Á; Revert-Ventura A; Martí-Bonmatí L; García-Gómez JM
    Radiology; 2018 Jun; 287(3):944-954. PubMed ID: 29357274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
    Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R
    Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
    Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
    Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Volumetric Analysis of Postoperative Magnetic Resonance Imaging Predicts Survival in Patients with Glioblastoma.
    Krivoshapkin AL; Sergeev GS; Gaytan AS; Kalneus LE; Kurbatov VP; Abdullaev OA; Salim N; Bulanov DV; Simonovich AE
    World Neurosurg; 2019 Jun; 126():e1510-e1517. PubMed ID: 30910753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
    Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
    Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression based overall survival prediction of glioblastoma multiforme patients using a single discovery cohort of multi-institutional multi-channel MR images.
    Sanghani P; Ang BT; King NKK; Ren H
    Med Biol Eng Comput; 2019 Aug; 57(8):1683-1691. PubMed ID: 31104273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
    Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
    Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
    Qin L; Li X; Stroiney A; Qu J; Helgager J; Reardon DA; Young GS
    Neuroradiology; 2017 Feb; 59(2):135-145. PubMed ID: 28070598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
    Pérez-Beteta J; Molina-García D; Ortiz-Alhambra JA; Fernández-Romero A; Luque B; Arregui E; Calvo M; Borrás JM; Meléndez B; Rodríguez de Lope Á; Moreno de la Presa R; Iglesias Bayo L; Barcia JA; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Revert A; Arana E; Pérez-García VM
    Radiology; 2018 Jul; 288(1):218-225. PubMed ID: 29924716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.
    Müller A; Jurcoane A; Kebir S; Ditter P; Schrader F; Herrlinger U; Tzaridis T; Mädler B; Schild HH; Glas M; Hattingen E
    Cancer Med; 2017 Jan; 6(1):89-99. PubMed ID: 27891815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
    Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
    Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.